Table: Kringle Pharma - 9-MTH parent results

Kringle Pharma

13/08/2021 08:00

Aug 13 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Jun 30, 2021        Jun 30, 2020      Sep 30, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            117 mln             61 mln            277 mln    
                 (+91.4 pct)                           (+40.7 pct)  
  Operating     loss 304 mln        loss 222 mln      loss 388 mln  
  Recurring     loss 245 mln        loss 166 mln      loss 328 mln  
  Net           loss 246 mln        loss 167 mln      loss 330 mln  
  EPS          loss 60.13 yen      loss 160.57 yen   loss 80.67 yen 
  Ann Div                                NIL               NIL      
  -Q3 div            NIL                                            
  -Q4 div                                NIL               NIL      
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T